Playback speed
10 seconds
Atezolizumab in First Line Metastatic NSCLC: Early Clinical Results from the IMpower150 Trial
By
Beacon Medical Interchange
FEATURING
Jack West
By
Beacon Medical Interchange
FEATURING
Jack West
9 views
November 2, 2018
Dr. Jack West reviews the preliminary clinical results on the IMpower150 trial that tested the ...
read more ↘ value of adding the immune checkpoint inhibitor atezolizumab to carbo/paclitaxel/bevacizumab in patients with chemo-naïve advanced non-squamous NSCLC.
↖ read less
read more ↘ value of adding the immune checkpoint inhibitor atezolizumab to carbo/paclitaxel/bevacizumab in patients with chemo-naïve advanced non-squamous NSCLC.
↖ read less
Login to view comments.
Click here to Login
Lung